VEDOLIZUMAB RATES OF MUCOSAL HEALING IN CROHN'S DISEASE: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF REAL-WORLD

被引：0
|
作者：
Danese, Silvio
Kamble, Pravin
Yang, Jin
Le Moine, Jean-Gabriel
Khan, Shahnaz
Hawe, Emma
Agboton, Christian
Wang, Song
Irving, Peter M.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su463
引用
收藏
页码：S702 / S703
页数：2
相关论文
共 50 条
  • [41] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease
    Rajat Garg
    Manik Aggarwal
    Abdul Mohammed
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Indian Journal of Gastroenterology, 2023, 42 : 718 - 723
  • [42] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
  • [43] Effectiveness of ocriplasmin in real-world settings: A systematic literature review, meta-analysis, and comparison with randomized trials
    Khanani, Arshad M.
    Constantine, Ryan N.
    Blot, Koenraad H.
    Lescrauwaet, Benedicte
    Szurman, Peter
    ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E823 - E836
  • [44] A systematic literature review and meta-analysis of real-world interventions for cognitive ageing in healthy older adults
    Vaportzis, Eleftheria
    Niechcial, Malwina A.
    Gow, Alan J.
    AGEING RESEARCH REVIEWS, 2019, 50 : 110 - 130
  • [45] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 718 - 723
  • [46] PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB IN REAL-WORLD SETTINGS
    Chiorean, Michael V.
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Fan, Tao
    GASTROENTEROLOGY, 2020, 158 (06) : S407 - S408
  • [47] Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting
    Sands, Bruce
    Khalid, Javaria
    Barocas, Morris
    Raluy-Callado, Mireia
    Merinopoulou, Evie
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S26 - S26
  • [48] Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease
    Alipour, Omeed
    Gualti, Alakh
    Shao, Ling
    Zhang, Bing
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [49] Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease
    Omeed Alipour
    Alakh Gualti
    Ling Shao
    Bing Zhang
    BMC Gastroenterology, 21
  • [50] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
12345